Dr Elijah Nazarzadeh
Co-Founder and Chief Scientific Officer

About

Elijah Nazarzadeh, PhD, is the Co-Founder and Chief Scientific Officer of Nebu-Flow, responsible for technical developments. He has a PhD in Fluid Mechanics from King’s College London (UK). During his career, he has provided scientific consultation services to several companies in the field of emulsions and multiphase systems. Since 2015, he has worked as a postdoctoral researcher at the University of Glasgow (UK), where he developed the Nebu-Flow technology and led commercialisation activities. Dr Nazarzadeh received a Lee Lucas Award from the Institute of Physics (UK) for his exceptional efforts in development of the Nebu-Flow technology.

Contributions

PULMONARY

INNOVATIVE ACOUSTIC NEBULISER TECHNOLOGY

Andrea Cusack, Elijah Nazarzadeh and John Pritchard share insights into the company’s innovative nebuliser platform, designed to overcome the technical restrictions of current technologies that limit the delivery of advanced medicines to the lungs. They also share an update on the development of new digital features for the Nebu-Flow product range.

More contributions

EARLY INSIGHT

CREATING A PLATFORM FOR NEBULISATION OF A WIDE RANGE OF DRUG TYPES AND FORMULATIONS

Elijah Nazarzadeh and John Pritchard introduce Nebu~Flow – a novel class of nebuliser technology that represents a major step in the ability to deliver drugs efficiently to the lungs. overcoming the limitations of current systems and unlocking the potential of the inhalation route, including for systemic delivery.